Literature DB >> 13563654

Fibrinolysis in normal pregnancy.

J J BIEZENSKI, H C MOORE.   

Abstract

Keywords:  FIBRIN; PREGNANCY/blood in

Mesh：

Substances：

Year:  1958        PMID： 13563654      PMCID： PMC479782          DOI： 10.1136/jcp.11.4.306

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  10 in total

1.  [Titration of antifibrinolytic power of the human blood; description of a new method].

Authors:  A BOZZO; S PIOMELLI; F SCHETTINI
Journal:  Riv Ist Sieroter Ital       Date:  1956 Jul-Aug

2.  Inhibition of fibrinolysis by alimentary lipaemia.

Authors:  H B GREIG
Journal:  Lancet       Date:  1956-07-07       Impact factor: 79.321

3.  Fibrinolysis in labor and delivery.

Authors:  R R MARGULIS; J H LUZADRE; C P HODGKINSON
Journal:  Obstet Gynecol       Date:  1954-05       Impact factor: 7.661

4.  [Fibrinolysis in obstetrics and gynecology; findings in 1005 cases].

Authors:  U CICULLA; C LURASCHI
Journal:  Ann Ostet Ginecol       Date:  1953-02

5.  The lability of human fibrinolysin.

Authors:  S C TRUELOVE
Journal:  Clin Sci       Date:  1953-02       Impact factor: 6.124

6.  Evidence of an active fibrinolytic enzyme in the plasma of normal people with observations on inhibition associated with the presence of calcium.

Authors:  G R FEARNLEY; J M TWEED
Journal:  Clin Sci       Date:  1953-02       Impact factor: 6.124

7.  Observations on the inactivation of fibrinolytic activity in shed blood.

Authors:  G R FEARNLEY; R REVILL; J M TWEED
Journal:  Clin Sci       Date:  1952-08       Impact factor: 6.124

8.  [Hematic fibrinolysis in pregnancy and puerperium].

Authors:  C CERVINI; G FICOLA
Journal:  Boll Soc Ital Biol Sper       Date:  1951 Sep-Nov

9.  The fibrinolysin-antifibrinolysin system in serum; mechanism of its endocrine control.

Authors:  G UNGAR; E DAMGAARD; F P HUMMEL
Journal:  Endocrinology       Date:  1951-12       Impact factor: 4.736

10.  Studies on the inhibition of proteolytic enzymes by serum. I. The mechanism of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with I131 as a substrate.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307
  10 in total
  11 in total

1.  Antifibrinolytic activity in normal pregnancy.

Authors:  J J BIEZENSKI
Journal:  J Clin Pathol       Date:  1960-05       Impact factor: 3.411

2.  Fibrinolytic and antifibrinolytic activity in pregnancy.

Authors:  S S NAIDOO; M HATHORN; T GILLMAN
Journal:  J Clin Pathol       Date:  1960-05       Impact factor: 3.411

3.  Serum fibrin degradation products throughout normal pregnancy.

Authors:  D G Woodfield; S K Cole; A G Allan; J D Cash
Journal:  Br Med J       Date:  1968-12-14

4.  [Influence of nitrofurantoin on blood coagulation and fibrinolysis in pregnancy, puerperium and newborn infant].

Authors:  W D Junge
Journal:  Klin Wochenschr       Date:  1971-09-01

5.  Fibrinolytic activity in pregnancy.

Authors:  I S Menon
Journal:  Br Med J       Date:  1970-04-25

6.  Coagulation and fibrinolytic mechanisms during and after normal childbirth.

Authors:  J Bonnar; G P McNicol; A S Douglas
Journal:  Br Med J       Date:  1970-04-25

7.  Fibrinolytic enzyme system and pregnancy.

Authors:  J Bonnar; G P McNicol; A S Douglas
Journal:  Br Med J       Date:  1969-08-16

8.  Twelve cases of fatal cerebral infarction due to arterial occlusion in the absence of atheromatous stenosis or embolism.

Authors:  J H Adams; D I Graham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-12       Impact factor: 10.154

9.  The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Samuel S Edwin; Chia-Ling Nhan-Chang; Nandor Gabor Than; Chong Jai Kim; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-23

10.  Fibrin degradation products in pre-eclamptic toxaemia and eclampsia.

Authors:  A H Henderson; D J Pugsley; D P Thomas
Journal:  Br Med J       Date:  1970-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.